 | Monter d'un niveau |
Carlino, F., Diana, A., Ventriglia, A., Piccolo, A., Mocerino, C., Riccardi, F., Bilancia, D., Giotta, F., Antoniol, G., Famiglietti, V., Feliciano, S., Cangiano, R., Lobianco, L., Pellegrino, B., De Vita, F., Ciardiello, F., & Orditura, M. (2022). HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study. Cancers, 14(20), 4981 (11 pages). Lien externe
